198 related articles for article (PubMed ID: 19494006)
41. Cytokine-Mediated Activation of NK Cells during Viral Infection.
Freeman BE; Raué HP; Hill AB; Slifka MK
J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
[TBL] [Abstract][Full Text] [Related]
42. Murine cytomegalovirus regulation of NKG2D ligands.
Lenac T; Arapović J; Traven L; Krmpotić A; Jonjić S
Med Microbiol Immunol; 2008 Jun; 197(2):159-66. PubMed ID: 18259774
[TBL] [Abstract][Full Text] [Related]
43. Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages.
Thompson TW; Jackson BT; Li PJ; Wang J; Kim AB; Huang KTH; Zhang L; Raulet DH
Elife; 2018 May; 7():. PubMed ID: 29757143
[TBL] [Abstract][Full Text] [Related]
44. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
[TBL] [Abstract][Full Text] [Related]
45. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo.
Szomolanyi-Tsuda E; Liang X; Welsh RM; Kurt-Jones EA; Finberg RW
J Virol; 2006 May; 80(9):4286-91. PubMed ID: 16611887
[TBL] [Abstract][Full Text] [Related]
46. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
Cerwenka A; Bakker AB; McClanahan T; Wagner J; Wu J; Phillips JH; Lanier LL
Immunity; 2000 Jun; 12(6):721-7. PubMed ID: 10894171
[TBL] [Abstract][Full Text] [Related]
47. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.
Oppenheim DE; Roberts SJ; Clarke SL; Filler R; Lewis JM; Tigelaar RE; Girardi M; Hayday AC
Nat Immunol; 2005 Sep; 6(9):928-37. PubMed ID: 16116470
[TBL] [Abstract][Full Text] [Related]
48. Continuous engagement of a self-specific activation receptor induces NK cell tolerance.
Tripathy SK; Keyel PA; Yang L; Pingel JT; Cheng TP; Schneeberger A; Yokoyama WM
J Exp Med; 2008 Aug; 205(8):1829-41. PubMed ID: 18606857
[TBL] [Abstract][Full Text] [Related]
49. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
[TBL] [Abstract][Full Text] [Related]
50. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
51. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
[TBL] [Abstract][Full Text] [Related]
52. Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins.
Xie X; Dighe A; Clark P; Sabastian P; Buss S; Brown MG
J Virol; 2007 Jan; 81(1):229-36. PubMed ID: 17050600
[TBL] [Abstract][Full Text] [Related]
53. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
[TBL] [Abstract][Full Text] [Related]
54. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response.
Kielczewska A; Pyzik M; Sun T; Krmpotic A; Lodoen MB; Munks MW; Babic M; Hill AB; Koszinowski UH; Jonjic S; Lanier LL; Vidal SM
J Exp Med; 2009 Mar; 206(3):515-23. PubMed ID: 19255146
[TBL] [Abstract][Full Text] [Related]
55. Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets.
Depatie C; Chalifour A; Paré C; Lee SH; Vidal SM; Lemieux S
Int Immunol; 1999 Sep; 11(9):1541-51. PubMed ID: 10464175
[TBL] [Abstract][Full Text] [Related]
56. The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection.
Arapović J; Arapović M; Golemac M; Traven L; Tomac J; Rumora D; Ražić E; Krmpotić A; Jonjić S
Med Microbiol Immunol; 2015 Jun; 204(3):335-44. PubMed ID: 25809566
[TBL] [Abstract][Full Text] [Related]
57. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
Wittenbrink M; Spreu J; Steinle A
Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
[TBL] [Abstract][Full Text] [Related]
58. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
[TBL] [Abstract][Full Text] [Related]
59. Repair of an Attenuated Low-Passage Murine Cytomegalovirus Bacterial Artificial Chromosome Identifies a Novel Spliced Gene Essential for Salivary Gland Tropism.
Redwood AJ; Masters LL; Chan B; Leary S; Forbes C; Jonjić S; Juranić Lisnić V; Lisnić B; Smith LM
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847854
[TBL] [Abstract][Full Text] [Related]
60. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation.
Corbett AJ; Coudert JD; Forbes CA; Scalzo AA
J Immunol; 2011 Feb; 186(3):1713-22. PubMed ID: 21187440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
